Procalcitonin Levels in Liver Transplantation
Author Information
Author(s): Eyraud Daniel, Ben Ayed Saïd, Tanguy Marie Laure, Vézinet Corinne, Siksik Jean Michel, Bernard Maguy, Fratéa Sylvia, Movschin Marie, Vaillant Jean-Christophe, Coriat Pierre, Hannoun Laurent
Primary Institution: Hôpital Pitié-Salpêtrière
Hypothesis
Can procalcitonin levels in donors or recipients predict early graft dysfunction and postoperative complications?
Conclusion
Procalcitonin levels in the donor and early peaks in the recipient are not predictive of post-liver transplantation complications.
Supporting Evidence
- Procalcitonin levels were measured in both donors and recipients before and after liver transplantation.
- High procalcitonin levels in donors were associated with cardiac arrest and infection.
- Postoperative peaks in procalcitonin levels were not linked to complications in recipients.
Takeaway
This study looked at a protein called procalcitonin in liver transplant patients to see if it could help predict problems after surgery, but it turns out it doesn't really help with that.
Methodology
Procalcitonin serum concentrations were measured in 67 brain-dead donors and their corresponding recipients before and after liver transplantation.
Potential Biases
Potential biases in donor selection and measurement techniques could affect results.
Limitations
The study may not account for all variables affecting procalcitonin levels and their predictive value.
Participant Demographics
67 patients (19 women and 48 men) with various causes for liver transplantation.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI 24.1 to 40.1
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website